Aflac (AFL)
NYSEFinancialsInsurance - LifeSnapshot 2026-09-04
$117.21-0.97%
Close 2026-09-04 · 1-day change
NYSEFinancialsInsurance - LifeSnapshot 2026-09-04
QuarterlyIQ Insights · AFL
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How this business ranks within financials on a research-validated quality screen. As of 2026-09-04.
The screen ranks AFL against its sector on four durable signals: share dilution, return on capital, free-cash-flow yield, and FCF margin. Historically the highest-quality names tended toward better typical outcomes and fewer bad years over multi-year holds (strongest at three years, modest at one), and that pattern showed up even before the price moved. It characterizes business quality, not price direction.
Each leg is a sector-relative percentile (higher is better); 3 of 4 legs were available for this name. The composite is built from these four; the raw value follows each percentile for context.
A forward quality tilt, not a price prediction, and context for your own research rather than a recommendation. Not investment advice.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Financials names rated strong grew net income 67% of the time over the next year (vs 56% for the rest of the cohort, n=7680).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Met or beat guidance 50% of the last 2 guided quarters · -9.1% avg surprise
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Continue to drive sales and awareness of third sector insurance products like Miraito cancer insurance, Anshin Palette medical insurance, and Tsumitasu life insurance in Japan.
Stated as a priority in 6 of last 6 quarters. Management consistently emphasizes driving sales of third sector products Miraito, Anshin Palette, and Tsumitasu in Japan. Sales increased 23.2% to ¥20.7 billion in 2025-Q2 and 25.5% to ¥17.7 billion in 2026-Q1. This priority is delivering with sustained sales growth and product innovation.
“In Japan, we have secured new opportunities through successful product initiatives including Anshin Palette, Miraito, and Tsumitasu.”
“We have attracted new business through successful product initiatives, including Anshin Palette, Miraito, and Tsumitasu in Japan.”
“We continue to promote awareness for third sector protection to new and younger customers through our innovative first sector product Tsumitasu.”
“We continue to drive awareness for third sector protection to new and younger customers through our innovative first sector product Tsumitasu.”
“We continue to introduce the need for third sector protection to new and younger customers through our innovative first sector product Tsumitasu.”
“We have continued to focus on third sector products, including Miraito, our new cancer insurance product, while continuing to introduce these policies to new and younger customers through Tsumitasu.”
Continue generating strong capital and cash flows while maintaining prudent liquidity and capital management to support operations and shareholder returns.
Stated as a priority in 6 of last 6 quarters. Operating cash flow remained strong, ranging from $968M in 2026-Q1 to $1.25B in 2025-Q3. Shareholders' equity increased from $26.3B in 2025-Q1 to $30.3B in 2026-Q2. Management is delivering on maintaining strong capital and cash flows with prudent liquidity.
Continue the balanced approach of returning capital to shareholders through dividend increases and opportunistic share repurchases.
Stated as a priority in 6 of last 6 quarters. Dividends per share increased modestly from $0.58 in 2025-Q1 to $0.61 in 2026-Q2. Share repurchases were $1.0B in 2026-Q1 and $983M in 2026-Q2. Management is delivering on capital return with consistent dividend growth and significant share repurchases.
Drive profitable growth in the U.S. supplemental insurance business through improved sales, persistency, underwriting discipline, and expense management.
Stated as a priority in 6 of last 6 quarters. U.S. net earned premiums grew modestly from $1.5B in 2025-Q2 to $1.54B in 2026-Q2. Sales increased 2.6% in 2026-Q2 and 2.9% in 2026-Q1. Management emphasizes profitable growth via underwriting discipline and agent productivity, with delivery reflected in steady premium growth.
Over the trailing year it converted 0.94x of net income into operating cash flow. Historically, Financials names rated neutral grew net income 60% of the time over the next year (vs 57% for the rest of the cohort, n=9112).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity (low R² over the window).
7 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Financials names rated neutral grew net income 56% of the time over the next year (vs 58% for the rest of the cohort, n=3751).
Not investment advice. As of 2026-09-04.
“We continue to generate strong capital and cash flows while maintaining our commitment to prudent liquidity and capital management.”
“We continue to generate strong capital and cash flows while maintaining our commitment to prudent liquidity and capital management.”
“We continue to generate strong capital and cash flows while maintaining our commitment to prudent liquidity and capital management.”
“We continue to generate strong capital and cash flows while maintaining our commitment to prudent liquidity and capital management.”
“We continue to generate strong capital and cash flows while maintaining our commitment to prudent liquidity and capital management.”
“We continue to generate strong capital and cash flows while maintaining our commitment to prudent liquidity and capital management.”
“The company returned $1.3 billion to shareholders, consisting of $983 million in share repurchase and $309 million in dividends.”
“The company returned $1.3 billion to shareholders, consisting of $1.0 billion in share repurchase and $315 million in dividends.”
“In the fourth quarter, Aflac deployed $800 million in capital to repurchase 7.2 million shares.”
“In the third quarter, Aflac deployed $1.0 billion in capital to repurchase 9.3 million shares.”
“In the second quarter, Aflac deployed $829 million in capital to repurchase 7.9 million shares.”
“In the first quarter, Aflac deployed $900 million in capital to repurchase 8.5 million shares.”
“In the U.S., our focus is on meeting the evolving needs of employers and their employees with supplemental health products and related benefits.”
“We have attracted new business through group voluntary benefits, network dental and vision, as well as group life and disability in the U.S.”
“We continue to focus on more profitable growth through strong underwriting discipline and improved productivity of agents and brokers.”
“We continue to focus on more profitable growth through stronger underwriting discipline and improving the productivity of agents and brokers.”
“We continue to focus on more profitable growth through our stronger underwriting discipline and improving the productivity of agents and brokers.”
“We continue to focus on more profitable growth through our stronger underwriting discipline and improving the productivity of agents and brokers.”